Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 12,900 KRW
Change Today -250.00 / -1.90%
Volume 567.2K
As of 2:28 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

yuyu pharma inc (000220) Snapshot

Open
13,150
Previous Close
13,150
Day High
13,650
Day Low
12,800
52 Week High
05/14/15 - 15,650
52 Week Low
06/13/14 - 6,830
Market Cap
78.7B
Average Volume 10 Days
831.5K
EPS TTM
356.00
Shares Outstanding
6.1M
EX-Date
03/28/14
P/E TM
36.2x
Dividend
180.00
Dividend Yield
--
Current Stock Chart for YUYU PHARMA INC (000220)

Related News

No related news articles were found.

yuyu pharma inc (000220) Related Businessweek News

No Related Businessweek News Found

yuyu pharma inc (000220) Details

Yuyu Pharma, Inc. manufactures and sells pharmaceutical products in South Korea and internationally. Its prescription drugs include osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, hyperlipidemia, pulmonary tuberculosis therapy, migraine, arthrifuge, diabetic neuropathy therapy, antihistamine, urinary system, eczematous dermatitis drugs, and other circulatory system drugs, as well as antipyretic analgesic and anti-inflammatory agents, skeletal muscle relaxants, and antibiotics. The company also offers non-prescription drugs, quasi drugs, health supplements, and vitamins. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Founded in 1941

yuyu pharma inc (000220) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yuyu pharma inc (000220) Key Developments

ieCrowd Establishes an Alliance with YuYu Pharma Inc

ieCrowd announced that it has established an alliance with YuYu Pharma Inc., expanding ieCrowd's access to Southeast Asian consumer and B2B markets for its future products and market offerings. YuYu will serve as a strategic partner for developing and expanding markets for ieCrowd products in three countries -- South Korea, Malaysia and Indonesia. ieCrowd intends to develop strategic partnerships in targeted regions around the world for the purpose of establishing market and distribution access for ieCrowd's future innovations and products. This strategic partnership is focused on the development of clear paths to market for ieCrowd's future products in three important Southeast Asian economies and provides an opportunity for future growth in the surrounding Asian region. The alliance also provides ieCrowd with YuYu's expertise in establishing regulatory approvals for future products.

Yuyu Pharma, Inc., Annual General Meeting, May 30, 2014

Yuyu Pharma, Inc., Annual General Meeting, May 30, 2014., at 10:00 Korea Standard Time. Location: 983 wangamdong Chungbuk Jecheon Co.. Agenda: To consider the audit report and sales.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000220:KS 12,900.00 KRW -250.00

000220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000220.
View Industry Companies
 

Industry Analysis

000220

Industry Average

Valuation 000220 Industry Range
Price/Earnings 50.5x
Price/Sales 1.1x
Price/Book 0.9x
Price/Cash Flow 40.9x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YUYU PHARMA INC, please visit www.yuyu.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.